OCULAR THERAPEUTIX
Ocular Therapeutix, Inc. engages in the development and commercialization of ophthalmic therapeutic products using its proprietary hydrogel technology to address unmet or underserved needs in ophthalmology. Its products include ReSure Adherent Ocular Bandage, a synthetic ocular bandage for ophthalmic surgery; ReSure Sealant, a synthetic and biocompatible hydrogel that creates a temporary, soft, and lubricious surface barrier to protect clear corneal incisions in the immediate post-operative period; and prostaglandin analog punctum plugs that are hydrogel-based punctum plug depots to deliver prostaglandin analogs to treat glaucoma.
OCULAR THERAPEUTIX
Industry:
Biotechnology Health Care Medical Device
Founded:
2006-01-01
Address:
Bedford, Massachusetts, United States
Country:
United States
Website Url:
http://www.ocutx.com
Total Employee:
51+
Status:
Active
Contact:
(781)357-4000
Email Addresses:
[email protected]
Total Funding:
271.4 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Google Tag Manager WordPress Content Delivery Network Google Universal Analytics
Similar Organizations
Injectsense
Monitoring therapy effectiveness (glaucoma) through miniaturized, autonomous in-vivo sensing and data uploading to cloud database.
Intarcia Therapeutics
Intarcia Therapeutics develops therapies for diseases that require long-term chronic treatment.
Sirnaomics
Sirnaomics is a biopharmaceutical company developing therapeutics for critical human diseases by using RNA interference technology.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Sparta Group
Sparta Group investment in Series D - Ocular Therapeutix
Dan Burgess
Dan Burgess investment in Series D - Ocular Therapeutix
Versant Ventures
Versant Ventures investment in Series D - Ocular Therapeutix
Ascension Ventures
Ascension Ventures investment in Series D - Ocular Therapeutix
Polaris Venture Capital
Polaris Venture Capital investment in Series D - Ocular Therapeutix
Baxter International
Baxter International investment in Series D - Ocular Therapeutix
Polaris Partners
Polaris Partners investment in Series D - Ocular Therapeutix
Versant Ventures
Versant Ventures investment in Series D - Ocular Therapeutix
Ascension Ventures
Ascension Ventures investment in Series D - Ocular Therapeutix
SV Health Investors
SV Health Investors investment in Series D - Ocular Therapeutix
Key Employee Changes
| Date | New article |
|---|---|
| 2021-09-28 | Ocular Therapeutix™ Announces Appointment of Karen-Leigh Edwards as Senior Vice President of Technical Operations |
Official Site Inspections
http://www.ocutx.com Semrush global rank: 275.99 K Semrush visits lastest month: 240.75 K
- Host name: 141.193.213.20
- IP address: 141.193.213.20
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Ocular Therapeutix"
About - Ocular Therapeutix
Ocular Therapeutix, Inc. is a biopharmaceutical company committed to improving vision in the real world through the development and commercialization of innovative therapies for retinal diseases and other eye conditions.See details»
Open Positions - Ocular Therapeutix
Would you like to become part of our team? Browse open positions today!See details»
Ocular Therapeutix, Inc. | LinkedIn
Ocular Therapeutix, Inc. | 20,299 followers on LinkedIn. Ocular Therapeutix, Inc. (NASDAQ:OCUL) is a biopharmaceutical company focused on the formulation, development, and commercialization of ...See details»
Ocular Therapeutix, Inc. (OCUL)
See the company profile for Ocular Therapeutix, Inc. (OCUL) including business summary, industry/sector information, number of employees, business summary, corporate governance, key executives and ...See details»
Ocular Therapeutix™ Executive Chairman Pravin U.
Apr 15, 2024 About Dr. Dugel, Executive Chairman of the Board, Ocular Therapeutix. Pravin U. Dugel, MD has held previous leadership roles including President of IVERIC Bio, Inc., Managing Partner, Retinal ...See details»
Ocular Therapeutix™ Announces Board of Directors and …
Feb 22, 2024 Industry Leader and Retina Expert, Pravin U. Dugel, MD, Becomes Executive Chair Jeffrey S. Heier, MD to become Chief Scientific Officer, Peter K. Kaiser, MD to be …See details»
Ocular Therapeutix™ Announces Board of Directors ... - Markets …
Feb 22, 2024 Orbis International is a non-profit organization focused on ophthalmology training and education in the developing world. With Orbis, Dr. Dugel travels to developing countries to …See details»
Contact - Ocular Therapeutix
Facility/Organization * Email * Phone. Zip Code. Preferred Method of Contact ... [email protected] Bill Slattery, Jr. VP, Investor Relations. Follow Us On Social Media. X; …See details»
Ocular Therapeutix, Inc. (OCUL) Company Profile & Overview
Jul 25, 2014 Ticker Symbol: OCUL: Exchange: NASDAQ: Fiscal Year: January - December: Reporting Currency: USD: CIK Code: 0001393434: CUSIP Number: 67576A100: ISIN …See details»
Ocular Therapeutix - Overview, News & Similar companies
May 23, 2024 Ocular Therapeutix contact info: Phone number: (781) 357-4000 Website: www.ocutx.com What does Ocular Therapeutix do? Ocular Therapeutix, Inc. is a …See details»
Ocular Therapeutix™ Executive Chairman Pravin U ... - Markets …
Apr 15, 2024 Orbis International is a non-profit organization focused on ophthalmology training and education in the developing world. With Orbis, Dr. Dugel travels to developing countries to …See details»
Culture and Values | Ocular Therapeutix - ocutx.com
Meet some of our featured employees from across the organization: Alyssa Milano Senior Manager, Quality Control Learn More. Marcial Pacheco Associate Director, Calibration and …See details»
(NASDAQ: OCUL) OCULAR THERAPEUTIX
-20-15-10-5 0 5 10 15 20-300-200-100 0 100 200 300 month 11 csft: 249µm bcva: 176 letters (20/30) case study: in treatment naÏve subjects, axpaxli monotherapySee details»
Ocular Therapeutix, Inc. Announces $325.0 Million Private Placement
BEDFORD, Mass., Feb. 22, 2024 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (Nasdaq:OCUL) (the “Company”), a biopharmaceutical company committed to enhancing …See details»
Ocular Therapeutix, Inc. (Ocular Therapeutix, Inc.) - 药物管线_专利_ …
A live webcast of the fireside chat can be accessed by visiting the Investors section of the Company’s website at investors.ocutx.com. About Ocular Therapeutix, Inc. Ocular …See details»
Compliance - Ocular Therapeutix
If you are a Nevada resident, you may submit a verified request by contacting us by sending an email to [email protected] or calling 877-628-8998 to opt out of sales and we will record your …See details»
Ocular Therapeutix, Inc. (OCUL) - Yahoo Finance
Find the latest Ocular Therapeutix, Inc. (OCUL) stock quote, history, news and other vital information to help you with your stock trading and investing.See details»
OCULAR THERAPEUTIX, INC SECURITIES AND EXCHANGE …
Us67576a1007_110824.txt SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No: 4)See details»
Diversity, Equity & Inclusion | Ocular Therapeutix - ocutx.com
Equity refers to fair treatment, access, and opportunity for everyone within an organization. When striving for equity, organizations need to identify and remove barriers that have prevented …See details»